
Edwards Lifesciences Corporation EW
$ 89.07
-1.44%
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
585 M |
Market Cap[1] |
$ 52.1 B |
EBITDA (LTM) |
$ 1.42 B |
P/E (LTM) |
48.858696 |
P/S (LTM) |
8.664632 |
EPS (LTM) |
1.84 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Orthofix Medical
OFIX
|
$ 9.81 | -1.8 % | $ 388 M | Nasdaq Global Select Market,SPB | ||
|
TransMedics Group
TMDX
|
$ 70.74 | -1.83 % | $ 2.4 B | Nasdaq Global Market | ||
|
Abbott Laboratories
ABT
|
$ 103.7 | 1.17 % | $ 181 B | NYSE,SPB | ||
|
Electromed
ELMD
|
$ 26.37 | -1.86 % | $ 218 M | NYSE American | ||
|
Align Technology
ALGN
|
$ 154.51 | -0.64 % | $ 11.2 B | Nasdaq Global Select Market,SPB | ||
|
InMode Ltd.
INMD
|
$ 13.97 | -0.57 % | $ 903 M | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 71.11 | -2.13 % | $ 2.09 B | NYSE,SPB | ||
|
Apyx Medical Corporation
APYX
|
$ 2.37 | -1.66 % | $ 97.4 M | Nasdaq Global Select Market | ||
|
IRIDEX Corporation
IRIX
|
$ 0.75 | -2.18 % | $ 12.7 M | Nasdaq Global Select Market | ||
|
IRadimed Corporation
IRMD
|
$ 85.82 | -2.08 % | $ 1.09 B | Nasdaq Global Select Market | ||
|
Accuray Incorporated
ARAY
|
$ 0.13 | -2.91 % | $ 15.9 M | Nasdaq Global Select Market | ||
|
Aethlon Medical
AEMD
|
$ 5.05 | -2.7 % | $ 3.4 M | Nasdaq Capital Market | ||
|
Venus Concept
VERO
|
- | - | $ 726 K | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 6.07 | 0.83 % | $ 72.6 M | Nasdaq Capital Market | ||
|
Alphatec Holdings
ATEC
|
$ 11.11 | -2.2 % | $ 1.67 B | Nasdaq Global Select Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Medtronic PLC
MDT
|
$ 95.41 | -1.18 % | $ 122 B | NYSE,SPB | ||
|
Sientra
SIEN
|
- | -16.59 % | $ 10.3 M | Nasdaq Global Select Market | ||
|
AxoGen
AXGN
|
$ 38.06 | 3.76 % | $ 1.75 B | Nasdaq Capital Market,SPB | ||
|
Silk Road Medical, Inc
SILK
|
- | - | $ 1.07 B | Nasdaq Global Select Market,SPB | ||
|
Myomo
MYO
|
$ 1.21 | -0.82 % | $ 50.6 M | NYSE American | ||
|
Surgalign Holdings
SRGA
|
- | -32.98 % | $ 1.68 M | Nasdaq Global Select Market | ||
|
ShockWave Medical
SWAV
|
- | - | $ 12.3 B | Nasdaq Global Select Market,SPB | ||
|
Bio-Rad Laboratories
BIO
|
$ 369.95 | 1.68 % | $ 10.1 B | NYSE,SPB | ||
|
Abiomed
ABMD
|
- | - | $ 17.2 B | Nasdaq Global Select Market,SPB | ||
|
Titan Medical
TMDI
|
- | -26.32 % | $ 19.6 M | Nasdaq Global Select Market | ||
|
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | Nasdaq Global Select Market,SPB | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Outset Medical
OM
|
$ 4.1 | -1.68 % | $ 62.4 K | Nasdaq Global Select Market | ||
|
Bruker Corporation
BRKR
|
$ 57.59 | 0.49 % | $ 8.74 B | Nasdaq Global Select Market,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 45.69 | -0.7 % | $ 67.6 B | NYSE,SPB | ||
|
Inari Medical
NARI
|
- | - | $ 4.23 B | Nasdaq Global Select Market,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
PAVmed
PAVM
|
$ 2.17 | 5.85 % | $ 1.45 M | Nasdaq Capital Market | ||
|
Insulet Corporation
PODD
|
$ 149.01 | 0.6 % | $ 10.5 B | Nasdaq Global Select Market,SPB | ||
|
Profound Medical Corp.
PROF
|
$ 5.56 | -3.47 % | $ 168 M | Nasdaq Global Select Market | ||
|
AVITA Medical
RCEL
|
$ 15.51 | 0.58 % | $ 432 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Butterfly Network
BFLY
|
$ 6.76 | -0.81 % | $ 1.67 B | NYSE | ||
|
ClearPoint Neuro
CLPT
|
$ 9.14 | -1.19 % | $ 259 M | Nasdaq Capital Market | ||
|
Sintx Technologies
SINT
|
$ 1.58 | -3.66 % | $ 4.38 M | Nasdaq Capital Market | ||
|
CONMED Corporation
CNMD
|
$ 49.25 | -0.11 % | $ 1.53 B | NYSE,SPB | ||
|
Smith & Nephew plc
SNN
|
$ 30.83 | -0.11 % | $ 26.7 B | NYSE | ||
|
Sensus Healthcare
SRTS
|
$ 2.95 | 1.55 % | $ 48.2 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 5.27 | -12.31 % | $ 328 M | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
ThermoGenesis Holdings
THMO
|
- | -25.84 % | $ 171 K | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.